custom image

Hepatobiliary Cancers: Pathobiology and Translational Advances

March 22-24, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change


Hepatobiliary cancers, including hepatocellular carcinomas (HCC) and intrahepatic cholangiocarcinomas (iCCA), represent a major global health burden that continues to challenge biological researchers and clinicians alike. Hepatobiliary cancers are the second or third leading cause of cancer mortality worldwide, with over 840,000 new cases diagnosed in 2018. This Keystone Symposia meeting will be the first of its kind to focus specifically on this challenging disease. The meeting aims to integrate emerging basic and translational research with the clinical perspective, in order to advance our understanding of the pathobiology behind both HCC and iCCA, with the ultimate goal of guiding novel treatment and prevention strategies targeting these underlying mechanisms. 

The program will explore current challenges in the field, including (1) shifting etiological trends, focusing on mechanisms linked to cell injury, inflammation, and fibrogenesis; (2) roles of the microbiome and tumor microenvironment in affecting disease progression, therapeutic resistance, and immunosurveillance; (3) challenges of inter-and intra-tumoral heterogeneity; (4) identification of novel and more effective biomarker signatures for monitoring prognosis and treatments; (5) advances in “omics” for personalizing therapies; and (6) current and emerging trends in molecular and immune targeting. Moreover, this unique meeting is paired with a joint meeting on fatty liver disease, which is a perfect fit in lieu of the fact that non-alcoholic steatohepatitis is an important risk factor for hepatobiliary cancer. These joint meetings will foster new and productive research collaborations towards both basic and translational advances, as well as offer valuable training opportunities for basic researchers and clinician scientists.

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
for Short Talk Consideration:
February 9, 2021
ePoster Abstract Submission: March 8, 2021
Financial Aid Application: March 8, 2021

#VKSHepatoCancer21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration. 

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion


To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Program Details



Speaking at this eSymposia


Silvia Affo

Columbia University, USA


Jesper Bøje Andersen

University of Copenhagen, Denmark


Renumathy Dhanasekaran

Stanford University, USA


Hashem B. El-Serag

Baylor College of Medicine, USA


Gregory J. Gores

Mayo Clinic, USA




More program details will be available soon.


Subscribe to receive updates to the program for this meeting.


Email address:    






Sponsors


 
 




Additional Support



Funding for this conference was made possible (in part) by Grant No. 1R13CA260993-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support







The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image
custom image
custom image






Donate to Keystone Symposia


custom image